The February 2025 Model Shadow Stock Portfolio Update is now available online.

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

Shares of Palo Alto Networks (PANW) are down in after-hours trading after the cybersecurity company reported earnings for its ...

Revenue up 14% to $19.1 MillionAchieves GAAP Profitability and Positive Cash Flow from Operations RANCHO CUCAMONGA, Calif., Feb. 13, ...

Good morning, and welcome to the Conference Call for Tate & Lyle's Q3 Trading Statement. Your speakers today are Nick Hampton, Chief Executive; and Sarah Kuijlaars, Chief Financial Officer. I will now ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting ...

Denver’s Jamal Murray is climbing the Nuggets’ franchise leaderboard for most points in a game. Murray notched a career-high ...

Cisco's next quarterly call, which will reflect our fiscal year 2025 third-quarter results, will be on Wednesday, May 14, ...

The Company's Board of Directors (the "Board”) approved payment of the $0.0075 per share per month dividend beginning in ...

Fourth quarter net income of $1.21 per diluted share and adjusted operating income of $1.25 per diluted share; full year net income of $2.39 per diluted share and adjusted operating income of $2.56 pe ...